Eastman Chemical (NYSE: EMN) reported Q2 EPS of $2.15, $0.13 better than the analyst estimate of $2.02. Revenue for the quarter came in at $2.36 billion versus the consensus estimate of $2.36 billion.

GUIDANCE:

Eastman Chemical sees FY 2024 EPS of $7.40-$7.85, versus the consensus of $7.68.

For earnings history and earnings-related data on Eastman Chemical (EMN) click here.